PTAB Updates Procedures For Interim Director Review, PTAB Litigation Blog
Visit the PTAB Litigation Blog
Effective July 24, 2023, the Patent Office updated its procedures for Interim Director Review (“DR”) of PTAB decisions. The updated procedures include the following key provisions:
- Expanding the process to permit parties to request DR of PTAB decisions on institution in AIA proceedings;
- Providing updated guidance as to what types of issues the Director will consider in DR, as well as additional guidance on various topics, such as the initiation of DR at the sole discretion of the Director (sua sponte DR), remands to PTAB for further proceedings, and sanction authority of the Director;
- Providing the Director the option to delegate review to a new independent panel called the Delegated Rehearing Panel (“DRP”); and
- Creating a new Appeals Review Panel (“ARP”), which may be convened by the Director sua sponte, to review PTAB ex parte, reexamination, or reissue appeal decisions.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
